AMENDMENT NUMBER 1 TO LIMITED LIABILITY COMPANY AGREEMENT OF PSMA DEVELOPMENT COMPANY LLCLimited Liability Company Agreement • October 22nd, 2003 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment Number 1 is made this 22nd day of March, 2002 by and between Progenics Pharmaceuticals, Inc., a Delaware corporation (“Progenics”), CYTOGEN Corporation, a Delaware corporation (“CYTOGEN”) and PSMA Development Company LLC, a Delaware Limited Liability company (the “Company”), and amends the Limited Liability Company Agreement, dated June 15, 1999 (the “Agreement”), among Progenics, CYTOGEN and the Company. Unless otherwise defined herein, capitalized terms used in this Amendment Number 1 shall have the respective meanings ascribed to such terms in the Agreement.
MASTER VIROLOGIC SERVICES AGREEMENTMaster Virologic Services Agreement • October 22nd, 2003 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS MASTER VIROLOGIC SERVICES AGREEMENT (“Agreement”) IS MADE THIS 22nd day of May, 2002, between Progenics Pharmaceuticals, Inc. with an office located at 777 Old Saw Mill River Road, Tarrytown, New York 10591 (“Progenics”) and VIROLOGIC, INC. with an office located at 345 Oyster Point Blvd., South San Francisco, CA 94080 (“ViroLogic”).
